On July 11, 2025, Median Technologies signed a financial agreement with the European Investment Bank (EIB) for a new financing facility of up to €37.5 million, .

Median Technologies files European application for Class IIb CE marking of eyonis® LCS. Concurrently to CE marking, Median has also applied for ISO 13485 certification for the Quality Management System supporting the manufacturing of eyonis ® LCS.

Join us at the World Conference on Lung Cancer (WCLC) in Barcelona, Spain from September 6-9, 2025. Visit us at Booth #420 to discover the latest advancements in eyonis® LCS: our AI/ML technology-based Software as a Medical Device designed to support radiologists and pulmonologists in lung cancer screening.

Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS

Median will be exhibiting at the ESMO Congress on October 17 – 21 in Berlin. Happy to see you at Messe Berlin, Booth #4029!